WiLing Wednesdays Education Webinars
Women in Lymphoma is very grateful for the generous sponsorship from industry supporters around the world.
Thank you for your ongoing support of our projects!
:ducational webinars hosted by Women in Lymphoma are solely intended for professionals working in the field of lymphoma. All patients seeking guidance or support with a lymphoma diagnosis or treatment are advised to consult their specialist haematologist.
_____________________________________________________________________________________________ SERIES 19 - Japanese Series - September 2026
Session 1 - Sep 2 - Emerging therapeutic strategies for EBV-associated T/NK-cell neoplasms: a Japanese perspective - Dr Mika Ando, Dr Ayako Arai
Register: link will follow
Session 2 - Sep 9 - Pathogenesis and therapeutic innovation in ENKTL and ANKL - Dr Motoko Yamaguchi, Dr Ayumi Fuijmoto
Register: link will follow
Session 3 - Sep 16 - Tumor microenvironment and novel therapeutic targets in T/NK-cell neoplasms - Dr Mamiko Sakata-Yanagimoto, Dr Ai Kotani
Register: link will follow
Session 4 - Sep 23 - Immune landscape of lymphoid malignancies: from B-cell lymphoma to ATL - Dr Momoko Nishikori, Dr Yoko Suehiro
Register: link will follow
Session 5 - Sep 30 - Publishing in Hematology & Oncology: How to Get Your Work Accepted- Dr Aya Takemoto Tokaji
Register: link will follow
SERIES 18 - LATAM Series (the session will be in Spanish language) - May/Jun 2026
Session 1 - May 6 - Dificultades en diagnóstico en linfomas no Hodgkin: ¿Qué es necesario y relevante en la práctica clínica? - Marcela de Dios Soler, Leticia Quintanilla. Recording
Session 2 - May 13 - Linfoma Difuso de Células B Grandes (DLBCL): Innovación y Acceso - Anna Sureda, Carolina Mahuad. Recording
Session 3 - May 20 - LLC: De la Biologia a la Práctica Clinica. Nuevos Modelos de Resistencia Molecular y su Impacto Terapéutico - Romina Gamberale, Carolina Oliver. Recording
Session 4 - May 27 - Terapias Celulares en Linfoma De la investigación local al CAR-T: producción, regulación y experiencia regional - Gloria Iacoboni, Beatriz Wills, Sofia Grille. Recording
Session 5 - Jun 3 - Linfoma de Hodgkin: Innovación terapéutica, supervivencia y equidad - Carla Casulo, Astrid Pavlovsky. Recording
SERIES 17 - DLBCL - Feb/Mar 2026
Session 1 - Feb 11 - DLBCL in Elderly - Pallawi Torka, Emily Ayers. Recording
Session 2 - Feb 18 - Bispecifics in DLBCL - Jennifer Crombie, Eliza Hawkes. Recording
Session 3 - Feb 25 - Secondary CNS Lymphoma - Diva Baggio, Laskhmi Nayak. Recording.
Session 4 - Mar 4 - Circulating Tumor DNA in Large B cell Lymphoma - Martine Chamuleau, Sirpa Leppa. Recording
SERIES 16 - Mantle Cell Lymphoma - Oct/Nov 2025
Session 1 - Recent updates for frontline therapy of MCL - Maria Gomes da Silva, Christine Ryan. recording
Session 2 - Recent updates in high risk MCL - Anita Kumar, Morgane Cheminant. recording
Session 3 - Recent updates in relapsed/refractory MCL including novel agents - Eva Giné, Clémentine Sarkozy. recording
Session 4 - Recent updates on the role of MRD in MCL - Christiane Pott, Aurore Touzart. recording
SERIES 15 - PATHOGENS AND LYMPHOMA - July 2025
Session 1 - EBV and lymphomagenesis - Marie Donzel, Jennifer Amengual. recording
Session 2 - Microbiome in lymphomas - Catherine Diefenbach, Paola Ghione. recording
Session 3 - Do infectious agents drive lymphoma initiation? - Catherine Thieblemont, Ayako Arai. recording
Session 4 - Post-treatment risk for infection - Swetha Thiruvengadam, Sairah Ahmed, Mini Kamboj. recording
SERIES 14 - DEMYSTIFYING PHARMA - Apr/May 2025
Session 1 - Pharma Structure - Michelle Dawson, Nina Shah. recording
Session 2 - Industry Engagement - Clare Spooner, John Wahba, Suhaida Selamat. recording
Session 3 - Successful Research Collaboration - Julia Brain, Candice McCoy. recording
Session 4 - Careers in Pharma - Connie Batlevi, Jamie Hirata. recording
SERIES 13 - INDOLENT LYMPHOMA - Oct/Nov 2024
Session 1 - First step of lymphomagenesis (t14;18 & CREBBP) - Dr. Sandrine Roulland & The CPC in its niche - Dr. Karin Tarte. recording
Session 2 - Biological Determinants of Progression and Transformation of Follicular Lymphoma - Prof. Jess Okosun & Risk stratification versus genomic classification in FL - Carla Casulo, MD. recording
Session 3 - First line for LTB & HTB - Dr Clémentine Sarkozy & RELEVANCE and preliminary data on PET as a biomarker, including its combination with ctDNA, recent advances in radiomics - Dr Anne-Ségolène Cottereau. recording
Session 4 - DEBATE : High risk relapsed FL should be treated differently. FOR – Dr Kim Linton & AGAINST – Dr Astrid Pavlovsky. recording
Session 5 - Career Development. recording
SERIES 12 - HODGKIN LYMPHOMA - May/June 2024
Session 1 - Strategies to Tailor Treatment for Hodgkin Lymphoma. recording
Session 2 - Global Perspectives on Treatment of Newly Diagnosed and Relapsed/Refractory Hodgkin Lymphoma with a Focus on Advanced Stage. recording
Session 3 - Current/Forthcoming Clinical Trials in Hodgkin Lymphoma. recording
Session 4 - Nodular Lymphoma Predominant Hodgkin Lymphoma and Other Pathologic Phenomena in Hodgkin Lymphoma. recording
SERIES 11 – DLBCL - March/April 2024
Session 1 - Upfront DLBCL Therapy. recording
Session 2 - The Changing Algorithm in R/R DLBCL. recording
Session 3 - Expanding Novel Therapies in R/R DLBCL. recording
Session 4 - Tailoring Therapy in R/R DLBCL. recording
Session 5 - Update on DLBCL Classification. recording
SERIES 10 – CAREER DEVELOPMENT - Oct/Nov 2023
Session 1 - Navigating early career development: Mentorship and Academic Promotion. recording
Session 2 - Tips & Pearls for Publishing Success. recording
Session 3 - Identifying and Pursuing Research Opportunities and Cooperative work. recording
Session 4 - Making Meaning in the Second half of your Career – leadership planning and new experiences. recording
SERIES 9 – MANTLE CELL LYMPHOMA (MCL) - May 2023
Session 1 - MCL Treatment. recording
Session 2 - MCL Prognostication. recording
Session 3 - Pathogenesis & Biology. recording
SERIES 8 – CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) - Feb/Mar 2023
Session 1 - CLL frontline treatment/new drugs/global access. recording
Session 2 - Tough CLL. recording
Session 3 - Career Development. recording
Session 4 - Optimal Investigation of CLL - molecular studies, risk stratification & MRD. recording
SERIES 7 - LYMPHOMA & THE BRAIN - Sept/Oct 2022
Session 1 - PCSNL - Diagnosis and Treatment. recording
Session 2 - PSNSL - Elderly and side effects. recording
Session 3 - SCNSL and CAR-T. recording
Session 4 - Debate on CNS Prophylaxis. recording
Session 5 - Other brain lymphomas & imaging. recording
SERIES 6 - CELLULAR THERAPY - Apr/May 2022
Session 1- Defining Cellular Therapies. recording
Session 2 - CAR-T Cells in different clinical settings - Treatment of DLBCL/Treatment of FL, MCL, CLL. recording
Session 3 - Moving forward in CAR-T Cell - Mechanisms of Resistance/Modified CAR-T Strategies – Allo CAR-T, Dual CAR-T. recording
Session 4 - CAR-T Strategies vs. BiTes. recording
Session 5 - Global discussion on access, application, real-life experiences & challenges. recording
SERIES 5 - CAREER DEVELOPMENT - Mar/Apr 2022
Session 1 - APPs. recording
Session 2 - Legendary WiL. recording
SERIES 4 – INDOLENT LYMPHOMA - Oct/Nov 2021
Session 1 - Living with Follicular Lymphoma/Follicular Lymphoma pathogenesis and clonal evolution, transformed FL. recording
Session 2 - Risk stratification in Follicular Lymphoma/Utility of PET in Follicular Lymphoma. recording
Session 3 - Advances for treatment for Follicular Lymphoma/Treatment paradigms for relapsed and refractory Follicular Lymphoma. recording
Session 4A - Career Development with Change Champions and their Mentees. recording
Session 4B - Career Development with Change Champions and their Mentees. recording
Session 5 - Treatment options in Marginal Zone Lymphoma/Waldenstrom’s Macroglobulinemia. recording
SERIES 3 - T-CELL LYMPHOMA - Apr/May 2021
Session 1- Update on T-cell: Lymphoma HemPath review/Primary therapy of common peripheral T-cell lymphoma. recording
Session 2 - HemPath review of T-cell lymphomas common in Asia/Frontline & Salvage therapies for T-cell lymphomas common in Asia. recording
Session 3 - Treatment & outcome for relapsed T-cell lymphomas/Use of autologous & allogenuc transplant for T-cell lymphomas. recording
Session 4 - Newer therapies & Clinical trials for T-cell lymphomas/Case studies of T-cell lymphomas. recording
Session 5 - Career Development. recording
SERIES 2 - HODGKIN LYMPHOMA - Jan/Feb 2021
Session 1 - Harnessing The Immune System To Treat Hodgkin Lymphoma. recording
Session 2 - Radiation In HL: A Showcase Of An Ideal Therapeutic Ratio. recording
Session 3 - Optimising The Care Of Aya Hodgkin Lymphoma. recording
Session 4 - Hodgkin Lymphoma Cases: A Global Discussion. recording
Session 5 - Career Reflections. recording
SERIES 1 - DLBCL - Sept 2020
Unfortunately recordings are not available for this series.
Session 1 - How I Approach Newly Diagnosed DLBCL
Session 2 - How I manage relapsed DLBCL
Session 3 - PET-pearls & PET-pitfalls in DLBCL
Session 4 - DLBCL: Lessons learnt from LYSA clinical trials
Session 5 - CNS Prophylaxis in Diffuse Large B Cell Lymphoma